Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Oncology Letters is Scopus-indexed (Q3, CiteScore 3.7), WoS SCIE. Published by Spandidos Publications.
Checked against the index lists dated .
ISSN 1792-1074Verify ISSN ↗1792-1082Verify ISSN ↗
Publisher: Spandidos Publications
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 233 / 428 | 45th | Q3 |
| Cancer Research | 165 / 233 | 29th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2010–present, best quartile Q3, CiteScore 3.7.
Oncology Letters is Q3 in Oncology (rank 233 of 428) and Q3 in Cancer Research (rank 165 of 233), by CiteScore 2025.
Oncology Letters is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.7, which places it in quartile Q3 at the 45th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.652, quartile Q3, with an H-index of 97.
Oncology Letters is published by Spandidos Publications. Its print ISSN is 1792-1074 and its online ISSN is 1792-1082.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Oncology Letters has an h-index of 106 and a 2-year mean of 2.13 citations per paper (OpenAlex). Its Scopus CiteScore is 3.7, quartile Q3. On 2-year citations it ranks #183 of 424 Scopus journals in Oncology.
Oncology Letters published 585 papers in 2025; its busiest recent year was 2017 with 2,172. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 94 research articles (2026), authors are most often from China (78.2%), Japan (6.4%) and Taiwan (3.2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 359 retracted papers are recorded (22.7 per 1,000 papers). The Problematic Paper Screener flags 14 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.